Veterinary Vaccine Industry Research Report 2024
Summary
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, the global Veterinary Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The report will help the Veterinary Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
According to APO Research, the global Veterinary Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Veterinary Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Veterinary Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccine.
The report will help the Veterinary Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Veterinary Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merck
- Zoetis
- Boehringer Ingelheim
- Ceva
- CAHIC
- HVRI
- Ringpu Biology
- Yebio
- DHN
- WINSUN
- Elanco
- Virbac
- Jinyu Bio-Technology
- ChengDu Tecbond
- CAVAC
- Kyoto Biken Laboratories
- FATRO
- Vaksindo
- Bio-Labs
- Avimex Animal Health
- MEVAC
- Biovac
- Atafen
- Dyntec
- BioTestLab
- RVSRI
- Medion
- Live Attenuated Vaccines
- Inactivated Vaccines
- Others
- Livestock
- Swine
- Chicken
- Dog & Cat
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Veterinary Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Veterinary Vaccine Sales (2019-2030)
2.2.3 Global Veterinary Vaccine Market Average Price (2019-2030)
2.3 Veterinary Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Live Attenuated Vaccines
2.3.3 Inactivated Vaccines
2.3.4 Others
2.4 Veterinary Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Livestock
2.4.3 Swine
2.4.4 Chicken
2.4.5 Dog & Cat
2.4.6 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Veterinary Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Veterinary Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Veterinary Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Veterinary Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Veterinary Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Veterinary Vaccine, Product Type & Application
3.8 Global Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
3.9 Global Veterinary Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck Veterinary Vaccine Product Portfolio
4.1.5 Merck Recent Developments
4.2 Zoetis
4.2.1 Zoetis Company Information
4.2.2 Zoetis Business Overview
4.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Zoetis Veterinary Vaccine Product Portfolio
4.2.5 Zoetis Recent Developments
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Company Information
4.3.2 Boehringer Ingelheim Business Overview
4.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
4.3.5 Boehringer Ingelheim Recent Developments
4.4 Ceva
4.4.1 Ceva Company Information
4.4.2 Ceva Business Overview
4.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Ceva Veterinary Vaccine Product Portfolio
4.4.5 Ceva Recent Developments
4.5 CAHIC
4.5.1 CAHIC Company Information
4.5.2 CAHIC Business Overview
4.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CAHIC Veterinary Vaccine Product Portfolio
4.5.5 CAHIC Recent Developments
4.6 HVRI
4.6.1 HVRI Company Information
4.6.2 HVRI Business Overview
4.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 HVRI Veterinary Vaccine Product Portfolio
4.6.5 HVRI Recent Developments
4.7 Ringpu Biology
4.7.1 Ringpu Biology Company Information
4.7.2 Ringpu Biology Business Overview
4.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
4.7.5 Ringpu Biology Recent Developments
4.8 Yebio
4.8.1 Yebio Company Information
4.8.2 Yebio Business Overview
4.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Yebio Veterinary Vaccine Product Portfolio
4.8.5 Yebio Recent Developments
4.9 DHN
4.9.1 DHN Company Information
4.9.2 DHN Business Overview
4.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 DHN Veterinary Vaccine Product Portfolio
4.9.5 DHN Recent Developments
4.10 WINSUN
4.10.1 WINSUN Company Information
4.10.2 WINSUN Business Overview
4.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.10.4 WINSUN Veterinary Vaccine Product Portfolio
4.10.5 WINSUN Recent Developments
4.11 Elanco
4.11.1 Elanco Company Information
4.11.2 Elanco Business Overview
4.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Elanco Veterinary Vaccine Product Portfolio
4.11.5 Elanco Recent Developments
4.12 Virbac
4.12.1 Virbac Company Information
4.12.2 Virbac Business Overview
4.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Virbac Veterinary Vaccine Product Portfolio
4.12.5 Virbac Recent Developments
4.13 Jinyu Bio-Technology
4.13.1 Jinyu Bio-Technology Company Information
4.13.2 Jinyu Bio-Technology Business Overview
4.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
4.13.5 Jinyu Bio-Technology Recent Developments
4.14 ChengDu Tecbond
4.14.1 ChengDu Tecbond Company Information
4.14.2 ChengDu Tecbond Business Overview
4.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
4.14.5 ChengDu Tecbond Recent Developments
4.15 CAVAC
4.15.1 CAVAC Company Information
4.15.2 CAVAC Business Overview
4.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.15.4 CAVAC Veterinary Vaccine Product Portfolio
4.15.5 CAVAC Recent Developments
4.16 Kyoto Biken Laboratories
4.16.1 Kyoto Biken Laboratories Company Information
4.16.2 Kyoto Biken Laboratories Business Overview
4.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
4.16.5 Kyoto Biken Laboratories Recent Developments
4.17 FATRO
4.17.1 FATRO Company Information
4.17.2 FATRO Business Overview
4.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.17.4 FATRO Veterinary Vaccine Product Portfolio
4.17.5 FATRO Recent Developments
4.18 Vaksindo
4.18.1 Vaksindo Company Information
4.18.2 Vaksindo Business Overview
4.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Vaksindo Veterinary Vaccine Product Portfolio
4.18.5 Vaksindo Recent Developments
4.19 Bio-Labs
4.19.1 Bio-Labs Company Information
4.19.2 Bio-Labs Business Overview
4.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
4.19.5 Bio-Labs Recent Developments
4.20 Avimex Animal Health
4.20.1 Avimex Animal Health Company Information
4.20.2 Avimex Animal Health Business Overview
4.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
4.20.5 Avimex Animal Health Recent Developments
4.21 MEVAC
4.21.1 MEVAC Company Information
4.21.2 MEVAC Business Overview
4.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.21.4 MEVAC Veterinary Vaccine Product Portfolio
4.21.5 MEVAC Recent Developments
4.22 Biovac
4.22.1 Biovac Company Information
4.22.2 Biovac Business Overview
4.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.22.4 Biovac Veterinary Vaccine Product Portfolio
4.22.5 Biovac Recent Developments
4.23 Atafen
4.23.1 Atafen Company Information
4.23.2 Atafen Business Overview
4.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.23.4 Atafen Veterinary Vaccine Product Portfolio
4.23.5 Atafen Recent Developments
4.24 Dyntec
4.24.1 Dyntec Company Information
4.24.2 Dyntec Business Overview
4.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.24.4 Dyntec Veterinary Vaccine Product Portfolio
4.24.5 Dyntec Recent Developments
4.25 BioTestLab
4.25.1 BioTestLab Company Information
4.25.2 BioTestLab Business Overview
4.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.25.4 BioTestLab Veterinary Vaccine Product Portfolio
4.25.5 BioTestLab Recent Developments
4.26 RVSRI
4.26.1 RVSRI Company Information
4.26.2 RVSRI Business Overview
4.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.26.4 RVSRI Veterinary Vaccine Product Portfolio
4.26.5 RVSRI Recent Developments
4.27 Medion
4.27.1 Medion Company Information
4.27.2 Medion Business Overview
4.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.27.4 Medion Veterinary Vaccine Product Portfolio
4.27.5 Medion Recent Developments
5 GLOBAL VETERINARY VACCINE MARKET SCENARIO BY REGION
5.1 Global Veterinary Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Veterinary Vaccine Sales by Region: 2019-2030
5.2.1 Global Veterinary Vaccine Sales by Region: 2019-2024
5.2.2 Global Veterinary Vaccine Sales by Region: 2025-2030
5.3 Global Veterinary Vaccine Revenue by Region: 2019-2030
5.3.1 Global Veterinary Vaccine Revenue by Region: 2019-2024
5.3.2 Global Veterinary Vaccine Revenue by Region: 2025-2030
5.4 North America Veterinary Vaccine Market Facts & Figures by Country
5.4.1 North America Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Veterinary Vaccine Sales by Country (2019-2030)
5.4.3 North America Veterinary Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Veterinary Vaccine Market Facts & Figures by Country
5.5.1 Europe Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Veterinary Vaccine Sales by Country (2019-2030)
5.5.3 Europe Veterinary Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Veterinary Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Veterinary Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Veterinary Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Veterinary Vaccine Market Facts & Figures by Country
5.7.1 Latin America Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Veterinary Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Veterinary Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Veterinary Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Veterinary Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Veterinary Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Veterinary Vaccine Sales by Type (2019-2030)
6.1.1 Global Veterinary Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Veterinary Vaccine Revenue by Type (2019-2030)
6.2.1 Global Veterinary Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Veterinary Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Veterinary Vaccine Sales by Application (2019-2030)
7.1.1 Global Veterinary Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Veterinary Vaccine Revenue by Application (2019-2030)
7.2.1 Global Veterinary Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Veterinary Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Veterinary Vaccine Value Chain Analysis
8.1.1 Veterinary Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Veterinary Vaccine Production Mode & Process
8.2 Veterinary Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Veterinary Vaccine Distributors
8.2.3 Veterinary Vaccine Customers
9 GLOBAL VETERINARY VACCINE ANALYZING MARKET DYNAMICS
9.1 Veterinary Vaccine Industry Trends
9.2 Veterinary Vaccine Industry Drivers
9.3 Veterinary Vaccine Industry Opportunities and Challenges
9.4 Veterinary Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Veterinary Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Veterinary Vaccine Sales (2019-2030)
2.2.3 Global Veterinary Vaccine Market Average Price (2019-2030)
2.3 Veterinary Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Live Attenuated Vaccines
2.3.3 Inactivated Vaccines
2.3.4 Others
2.4 Veterinary Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Livestock
2.4.3 Swine
2.4.4 Chicken
2.4.5 Dog & Cat
2.4.6 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Veterinary Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Veterinary Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Veterinary Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Veterinary Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Veterinary Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Veterinary Vaccine, Product Type & Application
3.8 Global Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
3.9 Global Veterinary Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Business Overview
4.1.3 Merck Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Merck Veterinary Vaccine Product Portfolio
4.1.5 Merck Recent Developments
4.2 Zoetis
4.2.1 Zoetis Company Information
4.2.2 Zoetis Business Overview
4.2.3 Zoetis Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Zoetis Veterinary Vaccine Product Portfolio
4.2.5 Zoetis Recent Developments
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Company Information
4.3.2 Boehringer Ingelheim Business Overview
4.3.3 Boehringer Ingelheim Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Boehringer Ingelheim Veterinary Vaccine Product Portfolio
4.3.5 Boehringer Ingelheim Recent Developments
4.4 Ceva
4.4.1 Ceva Company Information
4.4.2 Ceva Business Overview
4.4.3 Ceva Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Ceva Veterinary Vaccine Product Portfolio
4.4.5 Ceva Recent Developments
4.5 CAHIC
4.5.1 CAHIC Company Information
4.5.2 CAHIC Business Overview
4.5.3 CAHIC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CAHIC Veterinary Vaccine Product Portfolio
4.5.5 CAHIC Recent Developments
4.6 HVRI
4.6.1 HVRI Company Information
4.6.2 HVRI Business Overview
4.6.3 HVRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 HVRI Veterinary Vaccine Product Portfolio
4.6.5 HVRI Recent Developments
4.7 Ringpu Biology
4.7.1 Ringpu Biology Company Information
4.7.2 Ringpu Biology Business Overview
4.7.3 Ringpu Biology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Ringpu Biology Veterinary Vaccine Product Portfolio
4.7.5 Ringpu Biology Recent Developments
4.8 Yebio
4.8.1 Yebio Company Information
4.8.2 Yebio Business Overview
4.8.3 Yebio Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Yebio Veterinary Vaccine Product Portfolio
4.8.5 Yebio Recent Developments
4.9 DHN
4.9.1 DHN Company Information
4.9.2 DHN Business Overview
4.9.3 DHN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 DHN Veterinary Vaccine Product Portfolio
4.9.5 DHN Recent Developments
4.10 WINSUN
4.10.1 WINSUN Company Information
4.10.2 WINSUN Business Overview
4.10.3 WINSUN Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.10.4 WINSUN Veterinary Vaccine Product Portfolio
4.10.5 WINSUN Recent Developments
4.11 Elanco
4.11.1 Elanco Company Information
4.11.2 Elanco Business Overview
4.11.3 Elanco Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Elanco Veterinary Vaccine Product Portfolio
4.11.5 Elanco Recent Developments
4.12 Virbac
4.12.1 Virbac Company Information
4.12.2 Virbac Business Overview
4.12.3 Virbac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Virbac Veterinary Vaccine Product Portfolio
4.12.5 Virbac Recent Developments
4.13 Jinyu Bio-Technology
4.13.1 Jinyu Bio-Technology Company Information
4.13.2 Jinyu Bio-Technology Business Overview
4.13.3 Jinyu Bio-Technology Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
4.13.5 Jinyu Bio-Technology Recent Developments
4.14 ChengDu Tecbond
4.14.1 ChengDu Tecbond Company Information
4.14.2 ChengDu Tecbond Business Overview
4.14.3 ChengDu Tecbond Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.14.4 ChengDu Tecbond Veterinary Vaccine Product Portfolio
4.14.5 ChengDu Tecbond Recent Developments
4.15 CAVAC
4.15.1 CAVAC Company Information
4.15.2 CAVAC Business Overview
4.15.3 CAVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.15.4 CAVAC Veterinary Vaccine Product Portfolio
4.15.5 CAVAC Recent Developments
4.16 Kyoto Biken Laboratories
4.16.1 Kyoto Biken Laboratories Company Information
4.16.2 Kyoto Biken Laboratories Business Overview
4.16.3 Kyoto Biken Laboratories Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.16.4 Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
4.16.5 Kyoto Biken Laboratories Recent Developments
4.17 FATRO
4.17.1 FATRO Company Information
4.17.2 FATRO Business Overview
4.17.3 FATRO Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.17.4 FATRO Veterinary Vaccine Product Portfolio
4.17.5 FATRO Recent Developments
4.18 Vaksindo
4.18.1 Vaksindo Company Information
4.18.2 Vaksindo Business Overview
4.18.3 Vaksindo Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.18.4 Vaksindo Veterinary Vaccine Product Portfolio
4.18.5 Vaksindo Recent Developments
4.19 Bio-Labs
4.19.1 Bio-Labs Company Information
4.19.2 Bio-Labs Business Overview
4.19.3 Bio-Labs Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.19.4 Bio-Labs Veterinary Vaccine Product Portfolio
4.19.5 Bio-Labs Recent Developments
4.20 Avimex Animal Health
4.20.1 Avimex Animal Health Company Information
4.20.2 Avimex Animal Health Business Overview
4.20.3 Avimex Animal Health Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.20.4 Avimex Animal Health Veterinary Vaccine Product Portfolio
4.20.5 Avimex Animal Health Recent Developments
4.21 MEVAC
4.21.1 MEVAC Company Information
4.21.2 MEVAC Business Overview
4.21.3 MEVAC Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.21.4 MEVAC Veterinary Vaccine Product Portfolio
4.21.5 MEVAC Recent Developments
4.22 Biovac
4.22.1 Biovac Company Information
4.22.2 Biovac Business Overview
4.22.3 Biovac Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.22.4 Biovac Veterinary Vaccine Product Portfolio
4.22.5 Biovac Recent Developments
4.23 Atafen
4.23.1 Atafen Company Information
4.23.2 Atafen Business Overview
4.23.3 Atafen Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.23.4 Atafen Veterinary Vaccine Product Portfolio
4.23.5 Atafen Recent Developments
4.24 Dyntec
4.24.1 Dyntec Company Information
4.24.2 Dyntec Business Overview
4.24.3 Dyntec Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.24.4 Dyntec Veterinary Vaccine Product Portfolio
4.24.5 Dyntec Recent Developments
4.25 BioTestLab
4.25.1 BioTestLab Company Information
4.25.2 BioTestLab Business Overview
4.25.3 BioTestLab Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.25.4 BioTestLab Veterinary Vaccine Product Portfolio
4.25.5 BioTestLab Recent Developments
4.26 RVSRI
4.26.1 RVSRI Company Information
4.26.2 RVSRI Business Overview
4.26.3 RVSRI Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.26.4 RVSRI Veterinary Vaccine Product Portfolio
4.26.5 RVSRI Recent Developments
4.27 Medion
4.27.1 Medion Company Information
4.27.2 Medion Business Overview
4.27.3 Medion Veterinary Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.27.4 Medion Veterinary Vaccine Product Portfolio
4.27.5 Medion Recent Developments
5 GLOBAL VETERINARY VACCINE MARKET SCENARIO BY REGION
5.1 Global Veterinary Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Veterinary Vaccine Sales by Region: 2019-2030
5.2.1 Global Veterinary Vaccine Sales by Region: 2019-2024
5.2.2 Global Veterinary Vaccine Sales by Region: 2025-2030
5.3 Global Veterinary Vaccine Revenue by Region: 2019-2030
5.3.1 Global Veterinary Vaccine Revenue by Region: 2019-2024
5.3.2 Global Veterinary Vaccine Revenue by Region: 2025-2030
5.4 North America Veterinary Vaccine Market Facts & Figures by Country
5.4.1 North America Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Veterinary Vaccine Sales by Country (2019-2030)
5.4.3 North America Veterinary Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Veterinary Vaccine Market Facts & Figures by Country
5.5.1 Europe Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Veterinary Vaccine Sales by Country (2019-2030)
5.5.3 Europe Veterinary Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Veterinary Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Veterinary Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Veterinary Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Veterinary Vaccine Market Facts & Figures by Country
5.7.1 Latin America Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Veterinary Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Veterinary Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Veterinary Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Veterinary Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Veterinary Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Veterinary Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Veterinary Vaccine Sales by Type (2019-2030)
6.1.1 Global Veterinary Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Veterinary Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Veterinary Vaccine Revenue by Type (2019-2030)
6.2.1 Global Veterinary Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Veterinary Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Veterinary Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Veterinary Vaccine Sales by Application (2019-2030)
7.1.1 Global Veterinary Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Veterinary Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Veterinary Vaccine Revenue by Application (2019-2030)
7.2.1 Global Veterinary Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Veterinary Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Veterinary Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Veterinary Vaccine Value Chain Analysis
8.1.1 Veterinary Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Veterinary Vaccine Production Mode & Process
8.2 Veterinary Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Veterinary Vaccine Distributors
8.2.3 Veterinary Vaccine Customers
9 GLOBAL VETERINARY VACCINE ANALYZING MARKET DYNAMICS
9.1 Veterinary Vaccine Industry Trends
9.2 Veterinary Vaccine Industry Drivers
9.3 Veterinary Vaccine Industry Opportunities and Challenges
9.4 Veterinary Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Veterinary Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Veterinary Vaccine Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Veterinary Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Veterinary Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Veterinary Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Veterinary Vaccine Average Price (USD/Doses) of Manufacturers (2018-2023)
Table 11. Global Veterinary Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Veterinary Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merck Company Information
Table 17. Merck Business Overview
Table 18. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 19. Merck Veterinary Vaccine Product Portfolio
Table 20. Merck Recent Developments
Table 21. Zoetis Company Information
Table 22. Zoetis Business Overview
Table 23. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 24. Zoetis Veterinary Vaccine Product Portfolio
Table 25. Zoetis Recent Developments
Table 26. Boehringer Ingelheim Company Information
Table 27. Boehringer Ingelheim Business Overview
Table 28. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 29. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 30. Boehringer Ingelheim Recent Developments
Table 31. Ceva Company Information
Table 32. Ceva Business Overview
Table 33. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 34. Ceva Veterinary Vaccine Product Portfolio
Table 35. Ceva Recent Developments
Table 36. CAHIC Company Information
Table 37. CAHIC Business Overview
Table 38. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 39. CAHIC Veterinary Vaccine Product Portfolio
Table 40. CAHIC Recent Developments
Table 41. HVRI Company Information
Table 42. HVRI Business Overview
Table 43. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 44. HVRI Veterinary Vaccine Product Portfolio
Table 45. HVRI Recent Developments
Table 46. Ringpu Biology Company Information
Table 47. Ringpu Biology Business Overview
Table 48. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 49. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 50. Ringpu Biology Recent Developments
Table 51. Yebio Company Information
Table 52. Yebio Business Overview
Table 53. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 54. Yebio Veterinary Vaccine Product Portfolio
Table 55. Yebio Recent Developments
Table 56. DHN Company Information
Table 57. DHN Business Overview
Table 58. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 59. DHN Veterinary Vaccine Product Portfolio
Table 60. DHN Recent Developments
Table 61. WINSUN Company Information
Table 62. WINSUN Business Overview
Table 63. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 64. WINSUN Veterinary Vaccine Product Portfolio
Table 65. WINSUN Recent Developments
Table 66. Elanco Company Information
Table 67. Elanco Business Overview
Table 68. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 69. Elanco Veterinary Vaccine Product Portfolio
Table 70. Elanco Recent Developments
Table 71. Virbac Company Information
Table 72. Virbac Business Overview
Table 73. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 74. Virbac Veterinary Vaccine Product Portfolio
Table 75. Virbac Recent Developments
Table 76. Jinyu Bio-Technology Company Information
Table 77. Jinyu Bio-Technology Business Overview
Table 78. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 79. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 80. Jinyu Bio-Technology Recent Developments
Table 81. ChengDu Tecbond Company Information
Table 82. ChengDu Tecbond Business Overview
Table 83. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 84. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 85. ChengDu Tecbond Recent Developments
Table 86. CAVAC Company Information
Table 87. CAVAC Business Overview
Table 88. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 89. CAVAC Veterinary Vaccine Product Portfolio
Table 90. CAVAC Recent Developments
Table 91. Kyoto Biken Laboratories Company Information
Table 92. Kyoto Biken Laboratories Business Overview
Table 93. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 94. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 95. Kyoto Biken Laboratories Recent Developments
Table 96. FATRO Company Information
Table 97. FATRO Business Overview
Table 98. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 99. FATRO Veterinary Vaccine Product Portfolio
Table 100. FATRO Recent Developments
Table 101. Vaksindo Company Information
Table 102. Vaksindo Business Overview
Table 103. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 104. Vaksindo Veterinary Vaccine Product Portfolio
Table 105. Vaksindo Recent Developments
Table 106. Bio-Labs Company Information
Table 107. Bio-Labs Business Overview
Table 108. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 109. Bio-Labs Veterinary Vaccine Product Portfolio
Table 110. Bio-Labs Recent Developments
Table 111. Avimex Animal Health Company Information
Table 112. Avimex Animal Health Business Overview
Table 113. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 114. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 115. Avimex Animal Health Recent Developments
Table 116. MEVAC Company Information
Table 117. MEVAC Business Overview
Table 118. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 119. MEVAC Veterinary Vaccine Product Portfolio
Table 120. MEVAC Recent Developments
Table 121. Biovac Company Information
Table 122. Biovac Business Overview
Table 123. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 124. Biovac Veterinary Vaccine Product Portfolio
Table 125. Biovac Recent Developments
Table 126. Atafen Company Information
Table 127. Atafen Business Overview
Table 128. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 129. Atafen Veterinary Vaccine Product Portfolio
Table 130. Atafen Recent Developments
Table 131. Dyntec Company Information
Table 132. Dyntec Business Overview
Table 133. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 134. Dyntec Veterinary Vaccine Product Portfolio
Table 135. Dyntec Recent Developments
Table 136. BioTestLab Company Information
Table 137. BioTestLab Business Overview
Table 138. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 139. BioTestLab Veterinary Vaccine Product Portfolio
Table 140. BioTestLab Recent Developments
Table 141. RVSRI Company Information
Table 142. RVSRI Business Overview
Table 143. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 144. RVSRI Veterinary Vaccine Product Portfolio
Table 145. RVSRI Recent Developments
Table 146. Medion Company Information
Table 147. Medion Business Overview
Table 148. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 149. Medion Veterinary Vaccine Product Portfolio
Table 150. Medion Recent Developments
Table 151. Global Veterinary Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 152. Global Veterinary Vaccine Sales by Region (2018-2023) & (M Doses)
Table 153. Global Veterinary Vaccine Sales Market Share by Region (2018-2023)
Table 154. Global Veterinary Vaccine Sales by Region (2024-2029) & (M Doses)
Table 155. Global Veterinary Vaccine Sales Market Share by Region (2024-2029)
Table 156. Global Veterinary Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 157. Global Veterinary Vaccine Revenue Market Share by Region (2018-2023)
Table 158. Global Veterinary Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 159. Global Veterinary Vaccine Revenue Market Share by Region (2024-2029)
Table 160. North America Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 161. North America Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 162. North America Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 163. North America Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 164. North America Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 165. Europe Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 166. Europe Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 167. Europe Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 168. Europe Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 169. Europe Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 170. Asia Pacific Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 171. Asia Pacific Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 172. Asia Pacific Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 173. Asia Pacific Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 174. Asia Pacific Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 175. Latin America Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 176. Latin America Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 177. Latin America Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 178. Latin America Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 179. Latin America Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 180. Middle East and Africa Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 181. Middle East and Africa Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 182. Middle East and Africa Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 183. Middle East and Africa Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 184. Middle East and Africa Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 185. Global Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
Table 186. Global Veterinary Vaccine Sales by Type (2024-2029) & (M Doses)
Table 187. Global Veterinary Vaccine Sales Market Share by Type (2018-2023)
Table 188. Global Veterinary Vaccine Sales Market Share by Type (2024-2029)
Table 189. Global Veterinary Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 190. Global Veterinary Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 191. Global Veterinary Vaccine Revenue Market Share by Type (2018-2023)
Table 192. Global Veterinary Vaccine Revenue Market Share by Type (2024-2029)
Table 193. Global Veterinary Vaccine Price by Type (2018-2023) & (USD/Doses)
Table 194. Global Veterinary Vaccine Price by Type (2024-2029) & (USD/Doses)
Table 195. Global Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
Table 196. Global Veterinary Vaccine Sales by Application (2024-2029) & (M Doses)
Table 197. Global Veterinary Vaccine Sales Market Share by Application (2018-2023)
Table 198. Global Veterinary Vaccine Sales Market Share by Application (2024-2029)
Table 199. Global Veterinary Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 200. Global Veterinary Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 201. Global Veterinary Vaccine Revenue Market Share by Application (2018-2023)
Table 202. Global Veterinary Vaccine Revenue Market Share by Application (2024-2029)
Table 203. Global Veterinary Vaccine Price by Application (2018-2023) & (USD/Doses)
Table 204. Global Veterinary Vaccine Price by Application (2024-2029) & (USD/Doses)
Table 205. Key Raw Materials
Table 206. Raw Materials Key Suppliers
Table 207. Veterinary Vaccine Distributors List
Table 208. Veterinary Vaccine Customers List
Table 209. Veterinary Vaccine Industry Trends
Table 210. Veterinary Vaccine Industry Drivers
Table 211. Veterinary Vaccine Industry Restraints
Table 212. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Veterinary Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Veterinary Vaccine Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Veterinary Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Veterinary Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Veterinary Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Veterinary Vaccine Average Price (USD/Doses) of Manufacturers (2018-2023)
Table 11. Global Veterinary Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Veterinary Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merck Company Information
Table 17. Merck Business Overview
Table 18. Merck Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 19. Merck Veterinary Vaccine Product Portfolio
Table 20. Merck Recent Developments
Table 21. Zoetis Company Information
Table 22. Zoetis Business Overview
Table 23. Zoetis Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 24. Zoetis Veterinary Vaccine Product Portfolio
Table 25. Zoetis Recent Developments
Table 26. Boehringer Ingelheim Company Information
Table 27. Boehringer Ingelheim Business Overview
Table 28. Boehringer Ingelheim Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 29. Boehringer Ingelheim Veterinary Vaccine Product Portfolio
Table 30. Boehringer Ingelheim Recent Developments
Table 31. Ceva Company Information
Table 32. Ceva Business Overview
Table 33. Ceva Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 34. Ceva Veterinary Vaccine Product Portfolio
Table 35. Ceva Recent Developments
Table 36. CAHIC Company Information
Table 37. CAHIC Business Overview
Table 38. CAHIC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 39. CAHIC Veterinary Vaccine Product Portfolio
Table 40. CAHIC Recent Developments
Table 41. HVRI Company Information
Table 42. HVRI Business Overview
Table 43. HVRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 44. HVRI Veterinary Vaccine Product Portfolio
Table 45. HVRI Recent Developments
Table 46. Ringpu Biology Company Information
Table 47. Ringpu Biology Business Overview
Table 48. Ringpu Biology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 49. Ringpu Biology Veterinary Vaccine Product Portfolio
Table 50. Ringpu Biology Recent Developments
Table 51. Yebio Company Information
Table 52. Yebio Business Overview
Table 53. Yebio Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 54. Yebio Veterinary Vaccine Product Portfolio
Table 55. Yebio Recent Developments
Table 56. DHN Company Information
Table 57. DHN Business Overview
Table 58. DHN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 59. DHN Veterinary Vaccine Product Portfolio
Table 60. DHN Recent Developments
Table 61. WINSUN Company Information
Table 62. WINSUN Business Overview
Table 63. WINSUN Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 64. WINSUN Veterinary Vaccine Product Portfolio
Table 65. WINSUN Recent Developments
Table 66. Elanco Company Information
Table 67. Elanco Business Overview
Table 68. Elanco Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 69. Elanco Veterinary Vaccine Product Portfolio
Table 70. Elanco Recent Developments
Table 71. Virbac Company Information
Table 72. Virbac Business Overview
Table 73. Virbac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 74. Virbac Veterinary Vaccine Product Portfolio
Table 75. Virbac Recent Developments
Table 76. Jinyu Bio-Technology Company Information
Table 77. Jinyu Bio-Technology Business Overview
Table 78. Jinyu Bio-Technology Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 79. Jinyu Bio-Technology Veterinary Vaccine Product Portfolio
Table 80. Jinyu Bio-Technology Recent Developments
Table 81. ChengDu Tecbond Company Information
Table 82. ChengDu Tecbond Business Overview
Table 83. ChengDu Tecbond Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 84. ChengDu Tecbond Veterinary Vaccine Product Portfolio
Table 85. ChengDu Tecbond Recent Developments
Table 86. CAVAC Company Information
Table 87. CAVAC Business Overview
Table 88. CAVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 89. CAVAC Veterinary Vaccine Product Portfolio
Table 90. CAVAC Recent Developments
Table 91. Kyoto Biken Laboratories Company Information
Table 92. Kyoto Biken Laboratories Business Overview
Table 93. Kyoto Biken Laboratories Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 94. Kyoto Biken Laboratories Veterinary Vaccine Product Portfolio
Table 95. Kyoto Biken Laboratories Recent Developments
Table 96. FATRO Company Information
Table 97. FATRO Business Overview
Table 98. FATRO Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 99. FATRO Veterinary Vaccine Product Portfolio
Table 100. FATRO Recent Developments
Table 101. Vaksindo Company Information
Table 102. Vaksindo Business Overview
Table 103. Vaksindo Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 104. Vaksindo Veterinary Vaccine Product Portfolio
Table 105. Vaksindo Recent Developments
Table 106. Bio-Labs Company Information
Table 107. Bio-Labs Business Overview
Table 108. Bio-Labs Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 109. Bio-Labs Veterinary Vaccine Product Portfolio
Table 110. Bio-Labs Recent Developments
Table 111. Avimex Animal Health Company Information
Table 112. Avimex Animal Health Business Overview
Table 113. Avimex Animal Health Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 114. Avimex Animal Health Veterinary Vaccine Product Portfolio
Table 115. Avimex Animal Health Recent Developments
Table 116. MEVAC Company Information
Table 117. MEVAC Business Overview
Table 118. MEVAC Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 119. MEVAC Veterinary Vaccine Product Portfolio
Table 120. MEVAC Recent Developments
Table 121. Biovac Company Information
Table 122. Biovac Business Overview
Table 123. Biovac Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 124. Biovac Veterinary Vaccine Product Portfolio
Table 125. Biovac Recent Developments
Table 126. Atafen Company Information
Table 127. Atafen Business Overview
Table 128. Atafen Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 129. Atafen Veterinary Vaccine Product Portfolio
Table 130. Atafen Recent Developments
Table 131. Dyntec Company Information
Table 132. Dyntec Business Overview
Table 133. Dyntec Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 134. Dyntec Veterinary Vaccine Product Portfolio
Table 135. Dyntec Recent Developments
Table 136. BioTestLab Company Information
Table 137. BioTestLab Business Overview
Table 138. BioTestLab Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 139. BioTestLab Veterinary Vaccine Product Portfolio
Table 140. BioTestLab Recent Developments
Table 141. RVSRI Company Information
Table 142. RVSRI Business Overview
Table 143. RVSRI Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 144. RVSRI Veterinary Vaccine Product Portfolio
Table 145. RVSRI Recent Developments
Table 146. Medion Company Information
Table 147. Medion Business Overview
Table 148. Medion Veterinary Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 149. Medion Veterinary Vaccine Product Portfolio
Table 150. Medion Recent Developments
Table 151. Global Veterinary Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 152. Global Veterinary Vaccine Sales by Region (2018-2023) & (M Doses)
Table 153. Global Veterinary Vaccine Sales Market Share by Region (2018-2023)
Table 154. Global Veterinary Vaccine Sales by Region (2024-2029) & (M Doses)
Table 155. Global Veterinary Vaccine Sales Market Share by Region (2024-2029)
Table 156. Global Veterinary Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 157. Global Veterinary Vaccine Revenue Market Share by Region (2018-2023)
Table 158. Global Veterinary Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 159. Global Veterinary Vaccine Revenue Market Share by Region (2024-2029)
Table 160. North America Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 161. North America Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 162. North America Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 163. North America Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 164. North America Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 165. Europe Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 166. Europe Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 167. Europe Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 168. Europe Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 169. Europe Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 170. Asia Pacific Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 171. Asia Pacific Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 172. Asia Pacific Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 173. Asia Pacific Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 174. Asia Pacific Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 175. Latin America Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 176. Latin America Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 177. Latin America Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 178. Latin America Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 179. Latin America Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 180. Middle East and Africa Veterinary Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 181. Middle East and Africa Veterinary Vaccine Sales by Country (2018-2023) & (M Doses)
Table 182. Middle East and Africa Veterinary Vaccine Sales by Country (2024-2029) & (M Doses)
Table 183. Middle East and Africa Veterinary Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 184. Middle East and Africa Veterinary Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 185. Global Veterinary Vaccine Sales by Type (2018-2023) & (M Doses)
Table 186. Global Veterinary Vaccine Sales by Type (2024-2029) & (M Doses)
Table 187. Global Veterinary Vaccine Sales Market Share by Type (2018-2023)
Table 188. Global Veterinary Vaccine Sales Market Share by Type (2024-2029)
Table 189. Global Veterinary Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 190. Global Veterinary Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 191. Global Veterinary Vaccine Revenue Market Share by Type (2018-2023)
Table 192. Global Veterinary Vaccine Revenue Market Share by Type (2024-2029)
Table 193. Global Veterinary Vaccine Price by Type (2018-2023) & (USD/Doses)
Table 194. Global Veterinary Vaccine Price by Type (2024-2029) & (USD/Doses)
Table 195. Global Veterinary Vaccine Sales by Application (2018-2023) & (M Doses)
Table 196. Global Veterinary Vaccine Sales by Application (2024-2029) & (M Doses)
Table 197. Global Veterinary Vaccine Sales Market Share by Application (2018-2023)
Table 198. Global Veterinary Vaccine Sales Market Share by Application (2024-2029)
Table 199. Global Veterinary Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 200. Global Veterinary Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 201. Global Veterinary Vaccine Revenue Market Share by Application (2018-2023)
Table 202. Global Veterinary Vaccine Revenue Market Share by Application (2024-2029)
Table 203. Global Veterinary Vaccine Price by Application (2018-2023) & (USD/Doses)
Table 204. Global Veterinary Vaccine Price by Application (2024-2029) & (USD/Doses)
Table 205. Key Raw Materials
Table 206. Raw Materials Key Suppliers
Table 207. Veterinary Vaccine Distributors List
Table 208. Veterinary Vaccine Customers List
Table 209. Veterinary Vaccine Industry Trends
Table 210. Veterinary Vaccine Industry Drivers
Table 211. Veterinary Vaccine Industry Restraints
Table 212. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Veterinary VaccineProduct Picture
Figure 5. Global Veterinary Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Veterinary Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Veterinary Vaccine Sales (2018-2029) & (M Doses)
Figure 8. Global Veterinary Vaccine Average Price (USD/Doses) & (2018-2029)
Figure 9. Live Attenuated Vaccines Product Picture
Figure 10. Inactivated Vaccines Product Picture
Figure 11. Others Product Picture
Figure 12. Livestock Product Picture
Figure 13. Swine Product Picture
Figure 14. Chicken Product Picture
Figure 15. Dog & Cat Product Picture
Figure 16. Others Product Picture
Figure 17. Global Veterinary Vaccine Revenue Share by Manufacturers in 2022
Figure 18. Global Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
Figure 19. Global Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2022
Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. Global Veterinary Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. Global Veterinary Vaccine Sales by Region in 2022
Figure 24. Global Veterinary Vaccine Revenue by Region in 2022
Figure 25. North America Veterinary Vaccine Market Size by Country in 2022
Figure 26. North America Veterinary Vaccine Sales Market Share by Country (2018-2029)
Figure 27. North America Veterinary Vaccine Revenue Market Share by Country (2018-2029)
Figure 28. U.S. Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Veterinary Vaccine Market Size by Country in 2022
Figure 31. Europe Veterinary Vaccine Sales Market Share by Country (2018-2029)
Figure 32. Europe Veterinary Vaccine Revenue Market Share by Country (2018-2029)
Figure 33. Germany Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Veterinary Vaccine Market Size by Country in 2022
Figure 39. Asia Pacific Veterinary Vaccine Sales Market Share by Country (2018-2029)
Figure 40. Asia Pacific Veterinary Vaccine Revenue Market Share by Country (2018-2029)
Figure 41. China Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Veter
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Veterinary VaccineProduct Picture
Figure 5. Global Veterinary Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Veterinary Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Veterinary Vaccine Sales (2018-2029) & (M Doses)
Figure 8. Global Veterinary Vaccine Average Price (USD/Doses) & (2018-2029)
Figure 9. Live Attenuated Vaccines Product Picture
Figure 10. Inactivated Vaccines Product Picture
Figure 11. Others Product Picture
Figure 12. Livestock Product Picture
Figure 13. Swine Product Picture
Figure 14. Chicken Product Picture
Figure 15. Dog & Cat Product Picture
Figure 16. Others Product Picture
Figure 17. Global Veterinary Vaccine Revenue Share by Manufacturers in 2022
Figure 18. Global Manufacturers of Veterinary Vaccine, Manufacturing Sites & Headquarters
Figure 19. Global Manufacturers of Veterinary Vaccine, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Veterinary Vaccine Players Market Share by Revenue in 2022
Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. Global Veterinary Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. Global Veterinary Vaccine Sales by Region in 2022
Figure 24. Global Veterinary Vaccine Revenue by Region in 2022
Figure 25. North America Veterinary Vaccine Market Size by Country in 2022
Figure 26. North America Veterinary Vaccine Sales Market Share by Country (2018-2029)
Figure 27. North America Veterinary Vaccine Revenue Market Share by Country (2018-2029)
Figure 28. U.S. Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Veterinary Vaccine Market Size by Country in 2022
Figure 31. Europe Veterinary Vaccine Sales Market Share by Country (2018-2029)
Figure 32. Europe Veterinary Vaccine Revenue Market Share by Country (2018-2029)
Figure 33. Germany Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Veterinary Vaccine Market Size by Country in 2022
Figure 39. Asia Pacific Veterinary Vaccine Sales Market Share by Country (2018-2029)
Figure 40. Asia Pacific Veterinary Vaccine Revenue Market Share by Country (2018-2029)
Figure 41. China Veterinary Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Veter
